Premium
New Perspectives in Rheumatology: Biomarkers as Entry Criteria for Clinical Trials of New Therapies for Systemic Lupus Erythematosus: The Example of Antinuclear Antibodies and Anti‐DNA
Author(s) -
Pisetsky David S.,
Rovin Brad H.,
Lipsky Peter E.
Publication year - 2017
Publication title -
arthritis and rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.106
H-Index - 314
eISSN - 2326-5205
pISSN - 2326-5191
DOI - 10.1002/art.40008
Subject(s) - anti nuclear antibody , rheumatology , medicine , clinical trial , immunology , dermatology , systemic lupus erythematosus , antibody , autoantibody , disease